Education
About Us
Working with TipRanks
Follow Us
Earnings Calendar - Nov 13, 2024
Showing earnings announcements on Nov 13, 2024
Name | Company | Market Cap | EPS (Forecast) | EPS (Actual) | Revenue (Forecast) | Revenue (Actual) | Time | Analyst Consensus | Smart Score | Follow |
|---|---|---|---|---|---|---|---|---|---|---|
 | Cisco Systems | $279.21B | $0.87 | $13.78B | xxxxxxxxxxxxx | |||||
 | BioNano Genomics | $18.83M | -$11.85 | $7.76M | xxxxxxxxxxxxx | |||||
 | Tencent Holdings | $744.25B | $0.80 | $23.61B | xxxxxxxxxxxxx | |||||
 | Nu Holdings | $76.33B | $0.11 | $2.61B | xxxxxxxxxxxxx | |||||
 | Canoo | $43.46K | -$15.31 | $1.80M | xxxxxxxxxxxxx | |||||
 | Vaxart | $82.94M | -$0.10 | $1.93M | xxxxxxxxxxxxx | |||||
 | CyberArk Software | $25.84B | $0.46 | $234.10M | xxxxxxxxxxxxx | |||||
 | KULR Technology Group | $178.00M | -$0.16 | $2.40M | xxxxxxxxxxxxx | |||||
 | Paysafe | $746.76M | $0.61 | $423.15M | xxxxxxxxxxxxx | |||||
 | Stratasys | $1.02B | -$0.04 | $139.49M | xxxxxxxxxxxxx | |||||
 | Jaguar Animal Health | $7.78M | -$59.25 | $3.90M | xxxxxxxxxxxxx | |||||
 | Talphera | $52.42M | -$0.19 | $0.00 | xxxxxxxxxxxxx | |||||
 | ATAI Life Sciences | $1.51B | -$0.16 | $0.00 | xxxxxxxxxxxxx | |||||
 | Ecopetrol SA | $18.85B | $0.47 | $8.48B | xxxxxxxxxxxxx | |||||
 | Ceragon Networks | $225.65M | $0.09 | $101.51M | xxxxxxxxxxxxx | |||||
 | Tower | $8.47B | $0.54 | $370.30M | xxxxxxxxxxxxx | |||||
 | Innoviz Technologies | $405.57M | -$0.13 | $4.45M | xxxxxxxxxxxxx | |||||
 | Bitfarms | $2.55B | -$0.08 | $46.28M | xxxxxxxxxxxxx | |||||
 | Gilat | $954.83M | $0.07 | $76.77M | xxxxxxxxxxxxx | |||||
 | Spruce Power Holding | $46.55M | -$0.10 | $22.80M | xxxxxxxxxxxxx | |||||
 | Quantum | $139.32M | -$1.10 | $72.50M | xxxxxxxxxxxxx | |||||
 | Sonos | $2.10B | -$0.40 | $247.93M | xxxxxxxxxxxxx | |||||
 | Pagseguro Digital | $3.16B | $0.31 | $849.36M | xxxxxxxxxxxxx | |||||
 | Aytu BioScience | $22.50M | -$0.34 | $13.77M | xxxxxxxxxxxxx | |||||
 | Adaptimmune Therapeutics | $17.15M | >-$0.01 | $18.96M | xxxxxxxxxxxxx | |||||
 | HIVE Digital Technologies | $1.39B | -$0.10 | $24.98M | xxxxxxxxxxxxx | |||||
 | Gladstone Capital | $439.00M | $0.53 | $23.92M | xxxxxxxxxxxxx | |||||
 | Taysha Gene Therapies | $1.30B | -$0.09 | $1.74M | xxxxxxxxxxxxx | |||||
 | QXO Inc | $12.39B | $0.04 | $14.00M | xxxxxxxxxxxxx | |||||
 | Grace Therapeutics | $43.46M | -$0.37 | $0.00 | xxxxxxxxxxxxx | |||||
 | Astria Therapeutics | $702.05M | -$0.42 | $0.00 | xxxxxxxxxxxxx | |||||
 | Hut 8 | C$5.03B | -$0.28 | $34.43M | xxxxxxxxxxxxx | |||||
 | Capricor Therapeutics | $283.45M | -$0.36 | $4.28M | xxxxxxxxxxxxx | |||||
 | SELLAS Life Sciences Group | $248.91M | -$0.13 | $0.00 | xxxxxxxxxxxxx | |||||
 | Clene | $83.98M | -$1.33 | $107.00K | xxxxxxxxxxxxx | |||||
 | X4 Pharmaceuticals | $85.31M | -$5.14 | $1.69M | xxxxxxxxxxxxx | |||||
 | Boxlight | $9.59M | -$0.82 | $41.06M | xxxxxxxxxxxxx | |||||
 | Seres Therapeutics | $156.27M | -$1.55 | $31.00M | xxxxxxxxxxxxx | |||||
 | Structure Therapeutics, Inc. Sponsored ADR | $1.52B | -$0.18 | $0.00 | xxxxxxxxxxxxx | |||||
 | Cocrystal Pharma | $15.39M | -$0.57 | $0.00 | xxxxxxxxxxxxx | |||||
 | Helmerich & Payne | $2.55B | $0.80 | $695.99M | xxxxxxxxxxxxx | |||||
 | Electrocore | $39.82M | -$0.33 | $6.71M | xxxxxxxxxxxxx | |||||
 | Metagenomi, Inc. | $108.47M | -$0.78 | $6.76M | xxxxxxxxxxxxx | |||||
 | Leap Therapeutics | $19.83M | -$0.49 | $0.00 | xxxxxxxxxxxxx | |||||
 | Quince Therapeutics | $94.54M | -$0.17 | $0.00 | xxxxxxxxxxxxx | |||||
 | Loblaw Companies | $49.13B | $0.44 | $13.31B | xxxxxxxxxxxxx | |||||
 | Northland Power | $4.72B | $0.11 | $348.75M | xxxxxxxxxxxxx | |||||
 | Ontrak | $708.00 | -$1.56 | $2.60M | xxxxxxxxxxxxx | |||||
 | DLocal | $4.52B | $0.11 | $181.47M | xxxxxxxxxxxxx | |||||
 | American Bitcoin Corp | $5.11B | -$0.80 | $3.90M | xxxxxxxxxxxxx | |||||
 | Gyre Therapeutics | $742.05M | ― | ― | xxxxxxxxxxxxx | |||||
 | Perpetua Resources | $2.51B | -$0.10 | $0.00 | xxxxxxxxxxxxx | |||||
 | Vivani Medical | $95.98M | -$0.10 | $0.00 | xxxxxxxxxxxxx | |||||
 | Kyverna Therapeutics, Inc. | $321.75M | -$0.81 | $0.00 | xxxxxxxxxxxxx | |||||
 | Peyto Exploration & Dev | C$2.95B | $0.21 | $189.77M | xxxxxxxxxxxxx | |||||
 | Equillium | $83.90M | $0.02 | $11.55M | xxxxxxxxxxxxx | |||||
 | Omeros | $513.82M | -$0.70 | $0.00 | xxxxxxxxxxxxx | |||||
 | Unicycive Therapeutics | $90.60M | -$1.54 | $0.00 | xxxxxxxxxxxxx | |||||
 | Smith Micro Software | $15.34M | -$0.31 | $4.71M | xxxxxxxxxxxxx | |||||
 | Sutro Biopharma | $89.01M | -$0.73 | $15.29M | xxxxxxxxxxxxx | |||||
 | Oruka Therapeutics | $1.32B | -$0.40 | $0.00 | xxxxxxxxxxxxx | |||||
 | Mersana Therapeutics | $48.81M | -$4.29 | $7.53M | xxxxxxxxxxxxx | |||||
 | Kulicke & Soffa | $2.13B | $0.35 | $180.03M | xxxxxxxxxxxxx | |||||
 | Liquidia Technologies | $1.93B | -$0.37 | $4.16M | xxxxxxxxxxxxx | |||||
 | AFC Gamma | $77.27M | $0.34 | $12.41M | xxxxxxxxxxxxx | |||||
 | Passage Bio | $22.29M | -$4.64 | $1.67M | xxxxxxxxxxxxx | |||||
 | Bitcoin Depot | $211.76M | <$0.01 | $134.78M | xxxxxxxxxxxxx | |||||
 | Tetra Tech | $8.88B | $0.37 | $1.13B | xxxxxxxxxxxxx | |||||
 | Adial Pharmaceuticals | $7.91M | -$0.40 | $0.00 | xxxxxxxxxxxxx | |||||
 | Aethlon Medical | $4.10M | -$15.60 | $0.00 | xxxxxxxxxxxxx | |||||
 | Tenax Therapeutics | $33.72M | -$1.37 | $0.00 | xxxxxxxxxxxxx | |||||
 | Ellington Residential Mortgage | $200.41M | $0.31 | $5.56M | xxxxxxxxxxxxx | |||||
 | NioCorp Developments | $926.32M | ― | ― | xxxxxxxxxxxxx | |||||
 | Xos | $24.51M | -$1.35 | $22.80M | xxxxxxxxxxxxx | |||||
 | Cognition Therapeutics | $152.63M | -$0.20 | $0.00 | xxxxxxxxxxxxx | |||||
 | ESS Tech | $88.47M | -$1.68 | $5.25M | xxxxxxxxxxxxx | |||||
 | Fusion Fuel Green | $8.76M | -$0.27 | ― | $4.87M | ― | ― | xxxxxxxxxxxxx | ||
 | OptimizeRx | $402.49M | $0.06 | $24.99M | xxxxxxxxxxxxx | |||||
 | Cybin | $1.40M | -$0.95 | $0.00 | xxxxxxxxxxxxx | |||||
 | Diamedica Therapeutics | $355.62M | -$0.15 | $0.00 | xxxxxxxxxxxxx | |||||
 | Lucid Diagnostics | $175.65M | -$0.21 | $1.14M | xxxxxxxxxxxxx | |||||
 | Companhia Energetica Minas Gerais | $6.26B | $0.13 | $1.61B | xxxxxxxxxxxxx | |||||
 | Intellicheck Mobilisia | $95.38M | -$0.01 | $4.78M | xxxxxxxxxxxxx | |||||
 | Immuneering | $365.60M | -$0.55 | $0.00 | xxxxxxxxxxxxx | |||||
 | Predictive Oncology | $6.11M | -$4.80 | $500.00K | xxxxxxxxxxxxx | |||||
 | ARS Pharmaceuticals | $900.31M | -$0.14 | $575.00K | xxxxxxxxxxxxx | |||||
 | Arcos Dorados Holdings | $1.52B | $0.16 | $1.13B | xxxxxxxxxxxxx | |||||
 | SeaStar Medical Holding | $20.93M | -$1.13 | $75.00K | xxxxxxxxxxxxx | |||||
 | Harrow Health | $1.43B | -$0.05 | $52.80M | xxxxxxxxxxxxx | |||||
 | Venus Concept | $4.15M | -$12.48 | $17.27M | xxxxxxxxxxxxx | |||||
 | Banco do Brasil SA | $21.77B | $0.30 | $6.83B | xxxxxxxxxxxxx | |||||
 | Fulcrum Therapeutics | $498.72M | -$0.40 | $0.00 | xxxxxxxxxxxxx | |||||
 | Catheter Precision | $3.96M | -$41.80 | $100.00K | xxxxxxxxxxxxx | |||||
 | Safe Bulkers | $455.32M | $0.17 | $71.52M | xxxxxxxxxxxxx | |||||
 | Broadwind Energy | $55.07M | -$0.04 | $36.70M | xxxxxxxxxxxxx | |||||
 | Meiragtx Holdings | $701.50M | -$0.56 | $1.20M | xxxxxxxxxxxxx | |||||
 | Porsche Automobil Holding | $12.35B | ― | ― | ― | xxxxxxxxxxxxx | ||||
 | 4D Molecular Therapeutics | $529.61M | -$0.68 | $1.62M | xxxxxxxxxxxxx | |||||
 | Digi International | $1.44B | $0.47 | $104.16M | xxxxxxxxxxxxx | |||||
 | Mural Oncology Plc | $36.21M | -$1.97 | $0.00 | xxxxxxxxxxxxx |
Rows:
Earnings News
FAQ
When is Earnings Season?
The earnings season usually begins one to two weeks after the end of the last month of each quarter (December, March, June, and September).
How do earnings affect stock prices?
A company's earnings report reveals its profitability and financial stability. If a company’s earnings are reported above expectations, its stock price tends to rise. However, depending on forward guidance and macroeconomic factors, a stock price is still susceptible to volatility.
Is it better to buy a stock before or after earnings?
Stock prices tend to be more volatile before and after a company reports its earnings. Investors should develop an investment thesis using Earnings Reports Insights and other datasets before making any investment decisions.